Non-opioid Pain Patches Market

Report Highlights

The report broadly covers different types of Non-opioid Pain Patches based on their application or patch type. Furthermore, the scope of the report also covers the impact of COVID-19 and drivers and challenges for Non-opioid Pain Patches market. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each patch type, indication, distribution channel, and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional Non-opioid Pain Patches markets; it explains the major market drivers of the Global Non-opioid Pain Patches industry, current trends within the industry, major applications, and the regional dynamics of the Global Non-opioid Pain Patches Market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the Global Non-opioid Pain Patches Market.

Report Includes

• 36 tables and 44 figures
• An up-to-date analysis of the Global Non-opioid Pain Patches Market.
• Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
• Estimation of market size and revenue forecast for Global Non-opioid Pain Patches Market, and corresponding market share analysis by patch type, indication, distribution channel, and region.
• Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Non-opioid Pain Patches, identification of the companies that are best positioned to meet this demand.
• In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
• Identification of promising new products still in the development and testing stages, and their probability of successful commercial launch within the next five years
• Impact of COVID-19 on the Non-opioid Pain Patches Market as compared to overall global economy.
• Insight into the growth development strategies of major Non-opioid Pain Patches manufacturers and their key competitive landscape
• Descriptive company profiles of the leading market participants, including Endo International plc, Hisamitsu Pharmaceutical Co., Inc., Sanofi S.A., Sorrento Therapeutics, Inc., TEH SENG Pharmaceutical Mfg. Co., Ltd., and others.

Summary

Non-opioid pain patches are pain relief patches primarily used for releasing the medicine through the skin surface and supressing the transmission of the pain signal. Cancer, diabetes, and cardiovascular diseases are some of the main causes that have a deeper impact of pain. CVD is one of the major causes of death worldwide among the adults. Chronic pain initiates in abundant ways, for instance, pain initiated due to trauma mainly because of an accident or lifting heavy objects which could cause a back strain. The Non-opioid pain patches market is driven by the growth in the R&D sector to fabricate long-acting non-opioid pain patches which could have lesser side effects. Furthermore, rising prevalence of pituitary dysfunction is one of the major triggers for the market. Apart from that various industrial event such as, new product approvals, mergers and acquisitions, and launch of new products is going to strengthen the global non-opioid pain patches market.